The Discounted Cash Flow (DCF) valuation of Puma Biotechnology Inc (PBYI) is 8.11 USD. With the latest stock price at 3.39 USD, the upside of Puma Biotechnology Inc based on DCF is 139.2%.
Based on the latest price of 3.39 USD and our DCF valuation, Puma Biotechnology Inc (PBYI) is a buy. buying PBYI stocks now will result in a potential gain of 139.2%.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 10.0% | 8.5% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 6.60 - 10.62 | 8.11 |
| Upside | 94.8% - 213.3% | 139.2% |